Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sarah A. Carratt
Observed names:
Carratt, Sarah A.,
S A Carratt,
S.A. Carratt,
Sarah A Carratt,
Sarah Carratt
Institutions:
Oregon Health & Science University,
OHSU Knight Cancer Institute,
University of California, Davis
Observed institutions:
Oregon Health & Science University,
Pfizer (United States),
Loyola Marymount University,
OHSU Knight Cancer Institute,
University of California, Davis,
Seagen (United States)
show all 6
ORCID:
0000-0003-2493-6789
Observed ORCID:
0000-0003-2493-6789
OpenAlex ID:
A5001288243
An industry perspective on the FDA Modernization Act 2.0/3.0: potential next steps for sponsors to reduce animal use in drug development
2024
·
Sarah A Carratt
, Christina L Zuch de Zafra
, et al.
·
Toxicological Sciences
·
59
PDF
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
2019
·
Theodore P. Braun
, Mariam Okhovat
, et al.
·
Nature Communications
·
36
PDF
Human CYP2A13 and CYP2F1 Mediate Naphthalene Toxicity in the Lung and Nasal Mucosa of CYP2A13/2F1-Humanized Mice
2017
·
Lei Li
, Sarah Carratt
, et al.
·
Environmental Health Perspectives
·
33
PDF
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia
2020
·
Theodore P. Braun
, Cody Coblentz
, et al.
·
Proceedings of the National Academy of Sciences
·
31
Metabolism and Lung Toxicity of Inhaled Naphthalene: Effects of Postnatal Age and Sex
2019
·
Sarah A Carratt
, Nataliia Kovalchuk
, et al.
·
Toxicological Sciences
·
31
PDF
The Vedotin Antibody–Drug Conjugate Payload Drives Platform-Based Nonclinical Safety and Pharmacokinetic Profiles
2024
·
Haley D. Neff-LaFord
, Sarah A. Carratt
, et al.
·
Molecular Cancer Therapeutics
·
28
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia
2021
·
Sarah A. Carratt
, Theodore P. Braun
, et al.
·
Leukemia
·
24
PDF
Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R -driven myeloproliferative neoplasms
2022
·
Sarah A. Carratt
, Garth L. Kong
, et al.
·
Blood
·
21
PDF
Naphthalene genotoxicity: DNA adducts in primate and mouse airway explants
2019
·
Sarah A. Carratt
, Matthew Hartog
, et al.
·
Toxicology Letters
·
18
Naphthalene cytotoxicity in microsomal epoxide hydrolase deficient mice
2016
·
S.A. Carratt
, D. Morin
, et al.
·
Toxicology Letters
·
15
Novel multi-functional europium-doped gadolinium oxide nanoparticle aerosols facilitate the study of deposition in the developing rat lung
2016
·
Gautom K. Das
, Donald S. Anderson
, et al.
·
Nanoscale
·
13
Naphthalene DNA adduct formation and tolerance in the lung
2018
·
Bruce A. Buchholz
, Sarah A. Carratt
, et al.
·
Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms
·
11
Pesticides, wildfire suppression chemicals, and California wildfires: A human health perspective
2017
·
Sarah A. Carratt
, Cameron H. Flayer
, et al.
·
eScholarship (California Digital Library)
·
9
Comparison of acute respiratory epithelial toxicity for 4-Methylimidazole and naphthalene administered by oral gavage in B6C3F1 mice
2020
·
Jacklyn S. Kelty
, Chayoung Keum
, et al.
·
Regulatory Toxicology and Pharmacology
·
6
CITEViz: interactively classify cell populations in CITE-Seq via a flow cytometry-like gating workflow using R-Shiny
2024
·
Garth L. Kong
, Thai T. Nguyen
, et al.
·
BMC Bioinformatics
·
5
PDF
RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development
2023
·
Sarah A. Carratt
, Garth L. Kong
, et al.
·
Leukemia
·
4
PDF
Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia
2022
·
Sarah A. Carratt
, Theodore P. Braun
, et al.
·
Leukemia
·
3
Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report
2021
·
Sarah A. Carratt
, Diana Brewer
, et al.
·
Biomarker Research
·
3
PDF
Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling
2020
·
Sarah A Carratt
, Theodore P. Braun
, et al.
·
Blood
·
3
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
2022
·
Theodore P. Braun
, Mariam Okhovat
, et al.
·
Nature Communications
·
1
PDF
CITE-Viz: Replicating the Interactive Flow Cytometry Workflow in CITE-Seq
2022
·
Garth L. Kong
, Thai T. Nguyen
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
A Preliminary Study ofArgiope argentataas Indicators of Southern California Metal Contamination
2015
·
Sarah A. Carratt
, Martina G. Ramirez
·
Arachnology
·
1
Figure S2 from MYST Acetyltransferases Interact with SETBP1 and Are a Targetable Therapeutic Vulnerability in SETBP1-Mutant Leukemia
2026
·
Hanqian L. Carlson
, Thai T. Nguyen
, et al.
Figure S3 from MYST Acetyltransferases Interact with SETBP1 and Are a Targetable Therapeutic Vulnerability in SETBP1-Mutant Leukemia
2026
·
Hanqian L. Carlson
, Thai T. Nguyen
, et al.
Data from MYST Acetyltransferases Interact with SETBP1 and Are a Targetable Therapeutic Vulnerability in SETBP1-Mutant Leukemia
2026
·
Hanqian L. Carlson
, Thai T. Nguyen
, et al.
Show more works
View as search
Works count:
46
Citation count:
356
H-index:
11
I10-index:
12
Year
Topic
Type
